Clinical Trial

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Name: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants — clinical trial record (NCT07201558)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASSURO

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

Protocol Amendment History 1 change

notable Trial sites expanded: 19 -> 33 locations 2026-07-03

Trial Details

NCT Number	NCT07201558
Lead Sponsor	AstraZeneca
Conditions	Rheumatoid Arthritis, Systemic Lupus Erythematosus
Enrollment	48 participants
Start Date	2025-12-02
Primary Completion	2028-06-27 (estimated)
Study Completion	2028-06-27 (estimated)
Updated on ClinicalTrials.gov	2026-07-29